Anatomic Pathology Market
Global Anatomic Pathology Market Size, Share & Trends Analysis Report, by Products and Services (Anesthesiology, Consumables, Services, and Instruments), by Application (Disease Diagnosis and Drug Discovery), and by End-Users (Hospitals, Clinical Laboratory, Physician Laboratory, and Others) Forecast Period (2022-2028)
The global anatomic pathologymarket is anticipated to grow at a significant CAGR of 6.2% during the forecast period. The global anatomic pathology market is growing at a significant pace, owing to the increasing incidence and prevalence of chronic diseases, including kidney or liver diseases, infectious diseases, and cancer. Cancer cases are growing exponentially across the globe, with maximum patients suffering from colorectal, lung, prostate, and breast cancer. According to Breastcancer.org About 1 in 8 US women (about 13.0%) will develop invasive breast cancer throughout their lifetime. In 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the US, along with 51,400 new cases of non-invasive (in situ) breast cancer. Biomarkers are presenting a promising approach to the diagnosis of cancer and other diseases. The elevating use of biomarkers for the diagnosis of diseases is predicted to considerably accelerate the growth of the anatomic pathology market.
Impact of COVID-19 Pandemic on Global Anatomic Pathology Market
Globally, the COVID-19 pandemic has impacted the anatomic pathology market. Cancer patients have appeared as one of the worst affected patient groups in this pandemic. COVID-19 has had a profound influence on the number of patients undergoing cancer screening, diagnosis, and therapy. The increased pressure due to the growing rate of hospitalization of COVID-19 patients had directed to the re-profiling of numerous hospitals and departments, including oncology clinics, for treating patients with COVID-19. Therefore, many diagnostic and treatment procedures were canceled or delayed around the globe.
Segmental Outlook
The global anatomic pathology market is segmented based on products and services, applications, and end-users. Based on the products and services, the market is sectioned as anaesthesiology, consumables, services, and instruments. Based on the applications, the market is sectioned as disease diagnosis and drug discovery. Based on the end-users, the market is sectioned as hospitals, clinical laboratories, physician laboratories, and others. The above-mentioned segments can be customized as per the requirements. Among these the hospital segment holds a considerable share in the anatomic pathology market, as most of the patients depend more on the hospitals as compared to other healthcare facilities for the diagnosis of diseases, owing to the availability of well-equipped devices and developed monitoring software.
Global Anatomic Pathology Market Share by Application, 2021 (%)
The Disease Diagnostics Segment is Expected to Hold a Prominent Share in the Global Anatomic Pathology Market.
The disease diagnostics segment is expected to hold a prominent share in the global anatomic pathology market due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases. According to Eurostat, 20.6% population are aged 65 and over. The share of people aged 80 years and above in the EU population will be increased by 5.9% to 14.6% between 2020 to 2100.
Regional Outlooks
The global anatomic pathology market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Asia-Pacific region is expected to be the fastest-growing market due to the increase in healthcare expenditure and an increase in the patient pool in this region.
Global Anatomic Pathology Market Growth, by Region 2022-2028
The North America Region is Expected to hold the Prominent Share in the Global Anatomic Pathology Market
North America is estimated to contribute a significant share of the global anatomic pathology market. This is attributed to the increasing investment by government and academic research centers in diagnostic research, and the prevalence of lung cancer and other chronic diseases. Moreover, the growing elderly population and the high attention to biomarkers research, are some other factors that contribute to the market growth in the region. The presence of key market players, such as Abbott Laboratories, is further fuelling the growth of the market. Furthermore, the adoption of the Affordable Care Act and Healthcare reforms are expected to support the growth of the market during the forecast period. The presence of high-income groups and favorable reimbursement policies in North America is further attracting major market players in the region.
Market Players Outlook
The major companies serving the global Anatomic Pathology market Abcam plc, Abbott Laboratories, Agilent Technologies, Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021, F. Hoffmann-La Roche Ltd. introduced its automated digital pathology algorithms, uPath HER2 (4B5) image analysis, and uPath HER2 Dual ISH image analysis for breast cancer to assist determine the best treatment strategy for each patient. The image analysis algorithms use artificial intelligence to support pathologists in making fast, accurate patient diagnoses of breast cancer.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global anatomic pathology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Anatomic Pathology Market
• Recovery Scenario of Global Anatomic Pathology Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Agilent Technologies, Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Danaher Corp.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Abcam plc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Abbott Laboratories
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. F. Hoffmann-La Roche Ltd
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Anatomic Pathology Market by Products and Services
4.1.1. Anesthesiology
4.1.2. Consumables
4.1.3. Services
4.1.4. Instruments
4.2. Global Anatomic Pathology Market by Application
4.2.1. Disease Diagnosis
4.2.2. Drug Discovery
4.3. Global Anatomic Pathology Market by End Users
4.3.1. Hospitals
4.3.2. Clinical Laboratory
4.3.3. Physician Laboratory
4.3.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Advanced Cell Diagnostics, Inc.
6.2. Bio SB
6.3. Biocare Medical, LLC.
6.4. Biocartis NV
6.5. BioGenex Laboratories, Inc
6.6. Bruker Corp.
6.7. Diapath S.p.A.
6.8. Histo-line Laboratories
6.9. Laboratory Corporation of America
6.10. Lupetec
6.11. NeoGenomics Laboratories, Inc.
6.12. PHC Holdings Corp.
6.13. Quest Diagnostics Inc
6.14. Sakura Finetek USA, Inc.
6.15. Tecan Trading AG
1. GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2021-2028 ($ MILLION)
2. GLOBAL ANESTHESIOLOGYANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL CONSUMABLESANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SERVICES ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL INSTRUMENTS ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL ANATOMIC PATHOLOGY IN DISEASE DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL ANATOMIC PATHOLOGY IN DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
10. GLOBAL ANATOMIC PATHOLOGY FOR HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL ANATOMIC PATHOLOGY FOR CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL ANATOMIC PATHOLOGY FOR PHYSICIAN LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL ANATOMIC PATHOLOGY FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2021-2028 ($ MILLION)
17. NORTH AMERICAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. NORTH AMERICAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
19. EUROPEAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. EUROPEAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2021-2028 ($ MILLION)
21. EUROPEAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. EUROPEAN ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
27. REST OF THE WORLD ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. REST OF THE WORLD ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2021-2028 ($ MILLION)
29. REST OF THE WORLD ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
30. REST OF THE WORLD ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ANATOMIC PATHOLOGY MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ANATOMIC PATHOLOGY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ANATOMIC PATHOLOGY MARKET, 2022-2028 (%)
4. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE BY Products and Services, 2021 VS 2028 (%)
5. GLOBAL ANESTHESIOLOGYANATOMIC PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL CONSUMABLES ANATOMIC PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL SERVICES ANATOMIC PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL INSTRUMENTS ANATOMIC PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL ANATOMIC PATHOLOGY IN DISEASE DIAGNOSISMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL ANATOMIC PATHOLOGY IN DRUG DISCOVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE BY END USER, 2021 VS 2028 (%)
13. GLOBAL ANATOMIC PATHOLOGY FOR HOSPITALSMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL ANATOMIC PATHOLOGY FOR CLINICAL LABORATORY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL ANATOMIC PATHOLOGY FOR PHYSICIAN LABORATORY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL ANATOMIC PATHOLOGY FOR OTHERSMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. US ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
19. CANADA ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
20. UK ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
21. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
22. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
23. ITALY ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
24. SPAIN ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF EUROPE ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
26. INDIA ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
27. CHINA ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
28. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
29. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF THE WORLD ANATOMIC PATHOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
